▶ 調査レポート

止血検査の世界市場分析・規模・シェア・成長・動向・予測:製品種類別、検査種類別、最終用途別

• 英文タイトル:Hemostasis Diagnostics Market (Product Type - Laboratory Systems, Consumables, and Point-of-Care Testing Systems; Test Type - Prothrombin Test Time (PT), Activated Partial Thromboplastin Time (APTT), Fibrinogen Degradation Products (FDP), Activated Clotting Time, Platelet Aggregation Test, and D Dimer; End Users - Hospital/Clinics, Independent Diagnostic Laboratories, and Home Care Settings) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Transparency Market Researchが調査・発行した産業分析レポートです。止血検査の世界市場分析・規模・シェア・成長・動向・予測:製品種類別、検査種類別、最終用途別 / Hemostasis Diagnostics Market (Product Type - Laboratory Systems, Consumables, and Point-of-Care Testing Systems; Test Type - Prothrombin Test Time (PT), Activated Partial Thromboplastin Time (APTT), Fibrinogen Degradation Products (FDP), Activated Clotting Time, Platelet Aggregation Test, and D Dimer; End Users - Hospital/Clinics, Independent Diagnostic Laboratories, and Home Care Settings) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025 / TPM-B04332資料のイメージです。• レポートコード:TPM-B04332
• 出版社/出版日:Transparency Market Research / 2017年10月
• レポート形態:英文、PDF、189ページ
• 納品方法:Eメール
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥747,555 (USD5,795)▷ お問い合わせ
  Multi User¥1,134,555 (USD8,795)▷ お問い合わせ
  Global Site License¥1,521,555 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、止血検査の世界市場について調べ、止血検査の世界規模、市場動向、市場環境、製品種類別分析、検査種類別分析、最終用途別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、バリューチェーン分析、関連企業情報などをまとめた調査レポートです。
・序文・調査範囲・調査手法
・エグゼクティブサマリー
・止血検査の世界市場動向
・止血検査の世界市場環境
・止血検査のバリューチェーン分析
・止血検査の世界市場規模
・止血検査の世界市場規模:製品種類別
・止血検査の世界市場規模:検査種類別
・止血検査の世界市場規模:最終用途別
・止血検査の世界市場:地域別市場規模・分析
・止血検査の北米市場規模・予測
・止血検査のアメリカ市場規模・予測
・止血検査の中南米市場規模・予測
・止血検査のヨーロッパ市場規模・予測
・止血検査のアジア市場規模・予測
・止血検査の日本市場規模・予測
・止血検査の中国市場規模・予測
・止血検査のインド市場規模・予測
・止血検査の中東市場規模・予測
・止血検査のアフリカ市場規模・予測
・競争状況・関連企業情報

Hemostasis Diagnostics Market: Scope and Methodology

This report on the global hemostasis diagnostics market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2015 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the global hemostasis diagnostics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also provide insights into the key trends of the hemostasis diagnostics market such as augmentation in online services, increase in acceptance of disposable products and miniaturization. The key market indicators influencing global hemostasis diagnostics market taken into consideration including cost constraints and regulatory landscape. The report also includes market attractiveness analysis of the major segments that provides a thorough analysis of the overall competitive scenario in the global hemostasis diagnostics market. The report also highlights key events of the global hemostasis diagnostics industry. A porter’s five force analysis highlighting competitive landscape is also included in the report.

Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. The year on year growth of global hemostasis diagnostics market for each segment is also reflected. Additionally, market related factors such as technological advancements, rise in POCT in developed countries, and cost reduction for hospitals and greater affordability for patients in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Hemostasis Diagnostics Market: Segmentation

Based on product type, the global hemostasis diagnostics market has been segmented into laboratory systems, consumables, and point-of-care testing systems. On the basis of test type the market has been segmented into prothrombin test time (PT), activated partial thromboplastin time (APTT), fibrinogen degradation products (FDP), activated clotting time, platelet aggregation test, d dimer, and others. Based on end-user, the market has been segmented into hospital/clinics, independent diagnostic laboratories, home care settings, and others. Hospitals segment is expected to remain dominant during the forecast period.

Geographically, the global hemostasis diagnostics market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented into major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Australia, India, Japan, Brazil, and Mexico.

Hemostasis Diagnostics Market: Competitive Landscape

The report also profiles major players in the hemostasis diagnostics market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. A thorough market share analysis of major companies operating in the hemostasis diagnostics market is provided in the report. Key companies profiled in the report include Abbott Laboratories, Alere, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Sysmex Corporation, Siemens Healthineers, Instrumentation Laboratory, Danaher Corporation (Beckman Coulter), and Grifols, S.A.

The global hemostasis diagnostics market has been segmented as follows:

Global Hemostasis Diagnostics Market, by Product

Laboratory Systems
Automated Systems
Semi-automated Systems
Manual Systems
Consumables
Point-of-Care Testing Systems
Global Hemostasis Diagnostics Market, By Test Type

Prothrombin Test Time (PT)
Activated partial thromboplastin time (APTT)
Fibrinogen degradation products (FDP)
Activated Clotting Time
Platelet Aggregation Test
D Dimer
Others
Global Hemostasis Diagnostics Market, by End-user

Hospital/Clinics
Independent Diagnostic Laboratories
Home Care Settings
Others
Global Hemostasis Diagnostics Market, by Geography

North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
Australia
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC
Rest of Middle East & Africa

レポート目次

Section 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights

Section 2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology

Section 3 Executive Summary
3.1 Global Hemostasis Diagnostics: Market Snapshot
3.2 Market Share Analysis by Region, 2016
3.3 Market Opportunity Map

Section 4 Market Overview
4.1 Market Overview
4.2 Global Hemostasis Diagnostics Market: Market Indicators
4.3 Global Hemostasis Diagnostics Market: Key Industry Developments
4.4 Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
4.5 Global Hemostasis Diagnostics Market: Market Outlook

Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.2.1 Rise in prevalence of blood clotting disorders
5.2.2 High prevalence of cardiovascular diseases
5.2.3 Advancement in technology leading to easy usage
5.2.4 Increase in number of cancer patients
5.2.5 Rise in POCT in developed countries
5.2.6 Increase in usage of anticoagulant therapy
5.3 Restraints
5.3.1 Lack of awareness in developing countries
5.3.2 High cost of automated instruments
5.3.3 Regulatory challenges
5.4 Opportunities
5.4.1 Focusing on New Product Development
5.4.2 Mergers and Acquisitions and Strategic Alliances
5.5 Key Trends
5.6 Hemostasis Diagnostics Market: Porter’s Five Forces Analysis
5.7 Hemostasis Diagnostics Market: Value Chain Analysis
5.8 Coagulation Disorders & Coagulation Pathways: Overview
5.9 Epidemiology: Coagulation Disorders
5.10 Regulatory Framework
5.11 Reimbursement Scenario
5.12 Hemostasis Diagnostics Market: Pricing Analysis

Section 6 Hemostasis Diagnostics Market Analysis, by Product
6.1 Key Findings
6.2 Introduction
6.3 Global Hemostasis Diagnostics Market Value Share Analysis, by Product
6.4 Hemostasis Diagnostics Market Forecast, by Product
6.4.1 Laboratory Systems
6.4.1.1 Automated Systems
6.4.1.2 Semi-automated Systems
6.4.1.3 Manual Systems
6.4.2 Consumables
6.4.3 Point-of-Care Testing Systems

Section 7 Hemostasis Diagnostics Market Analysis, by Test Type
7.1 Key Findings
7.2 Introduction
7.3 Global Hemostasis Diagnostics Market Value Share Analysis, by Test Type
7.4 Hemostasis Diagnostics Market Forecast, by Test Type
7.4.1 Prothrombin Test Time (PT)
7.4.2 Activated partial thromboplastin time (APTT)
7.4.3 Fibrinogen degradation products (FDP)
7.4.4 Activated Clotting Time
7.4.5 Platelet Aggregation Test
7.4.6 D Dimer
7.4.7 Others
7.5 Market Attractiveness Analysis, by Test Type

Section 8 Hemostasis Diagnostics Market Analysis, by End-user
8.1 Key Findings
8.2 Introduction
8.3 Global Hemostasis Diagnostics Market Value Share Analysis, by End-user
8.4 Global Hemostasis Diagnostics Market Forecast, by End-user
8.4.1 Hospital/Clinics
8.4.2 Independent Diagnostic Laboratories
8.4.3 Home Care Settings
8.4.5 Others
8.5 Market Attractiveness Analysis, by End-user

Section 9 Hemostasis Diagnostics Market Analysis, by Region
9.1 Global Hemostasis Diagnostics Market, Global Market Scenario
9.2 Global Hemostasis Diagnostics Market Value Share Analysis, by Region
9.3 Hemostasis Diagnostics Market Forecast, by Region
9.4 Market Attractiveness Analysis, by Region

Section 10 North America Hemostasis Diagnostics Market Analysis
10.1 Regional Outlook
10.2 Market Overview
10.3 Market Analysis, by Product
10.3.1 Market Value Share Analysis, by Product
10.3.2 Market Size (US$ Mn) Forecast, by Product
10.3.2.1 Laboratory Systems
10.3.2.1.1 Automated Systems
10.3.2.1.2 Semi-automated Systems
10.3.2.1.3 Manual Systems
10.3.2.2 Consumables
10.3.2.3 Point-of-Care Testing Systems
10.4 Market Analysis, by Test Type
10.4.1 Market Value Share Analysis, by Test Type
10.4.2 Market Size (US$ Mn) Forecast, by Test Type
10.4.2.1 Prothrombin Test Time (PT)
10.4.2.2 Activated partial thromboplastin time (APTT)
10.4.2.3 Fibrinogen degradation products (FDP)
10.4.2.4 Activated Clotting Time
10.4.2.5 Platelet Aggregation Test
10.4.2.6 D Dimer
10.4.2.7 Others
10.4 Market Analysis, by End-user
10.4.1 Market Value Share Analysis, by End-user
10.4.2 Market Size (US$ Mn) Forecast, by End-user
10.4.2.1 Hospital/Clinics
10.4.2.2 Independent Diagnostic Laboratories
10.4.2.3 Home Care Settings
10.4.2.4 Others
10.5 Market Analysis, by Country
10.5.1 Market Value Share Analysis, by Country
10.5.2 Market Size (US$ Mn) Forecast, by Country, 2017–2025
10.5.2.1 U.S.
10.5.2.2 Canada
10.6 Market Attractiveness Analysis
10.6.1 by Product
10.6.2 by Test Type
10.6.3 by End-user

Section 11 Europe Hemostasis Diagnostics Market Analysis
11.1 Regional Outlook
11.2 Market Overview
11.3 Market Analysis, by Product
11.3.1 Market Value Share Analysis, by Product
11.3.2 Market Size (US$ Mn) Forecast, by Product
11.3.2.1 Laboratory Systems
11.3.2.1.1 Automated Systems
11.3.2.1.2 Semi-automated Systems
11.3.2.1.3 Manual Systems
11.3.2.2 Consumables
11.3.2.3 Point-of-Care Testing Systems
11.4 Market Analysis, by Test Type
11.4.1 Market Value Share Analysis, by Test Type
11.4.2 Market Size (US$ Mn) Forecast, by Test Type
11.4.2.1 Prothrombin Test Time (PT)
11.4.2.2 Activated partial thromboplastin time (APTT)
11.4.2.3 Fibrinogen degradation products (FDP)
11.4.2.4 Activated Clotting Time
11.4.2.5 Platelet Aggregation Test
11.4.2.6 D Dimer
11.4.2.7 Others
11.4 Market Analysis, by End-user
11.4.1 Market Value Share Analysis, by End-user
11.4.2 Market Size (US$ Mn) Forecast, by End-user
11.4.2.1 Hospital/Clinics
11.4.2.2 Independent Diagnostic Laboratories
11.4.2.3 Home Care Settings
11.4.2.4 Others
11.5 Market Analysis, by Country
11.5.1 Market Value Share Analysis, by Country
11.5.2 Market Size (US$ Mn) Forecast, by Country, 2017–2025
11.5.2.1 UK
11.5.2.2 Germany
11.5.2.3 France
11.5.2.4 Italy
11.5.2.5 Spain
11.5.2.6 Rest of Europe
11.6 Market Attractiveness Analysis
11.6.1 by Product
11.6.2 by Test Type
11.6.3 by End-user

Section 12 Asia Pacific Hemostasis Diagnostics Market Analysis
12.1 Regional Outlook
12.2 Market Overview
12.3 Market Analysis, by Product
12.3.1 Market Value Share Analysis, by Product
12.3.2 Market Size (US$ Mn) Forecast, by Product
12.3.2.1 Laboratory Systems
12.3.2.1.1 Automated Systems
12.3.2.1.2 Semi-automated Systems
12.3.2.1.3 Manual Systems
12.3.2.2 Consumables
12.3.2.3 Point-of-Care Testing Systems
12.4 Market Analysis, by Test Type
12.4.1 Market Value Share Analysis, by Test Type
12.4.2 Market Size (US$ Mn) Forecast, by Test Type
12.4.2.1 Prothrombin Test Time (PT)
12.4.2.2 Activated partial thromboplastin time (APTT)
12.4.2.3 Fibrinogen degradation products (FDP)
12.4.2.4 Activated Clotting Time
12.4.2.5 Platelet Aggregation Test
12.4.2.6 D Dimer
12.4.2.7 Others
12.4 Market Analysis, by End-user
12.4.1 Market Value Share Analysis, by End-user
12.4.2 Market Size (US$ Mn) Forecast, by End-user
12.4.2.1 Hospital/Clinics
12.4.2.2 Independent Diagnostic Laboratories
12.4.2.3 Home Care Settings
12.4.2.4 Others
12.5 Market Analysis, by Country
12.5.1 Market Value Share Analysis, by Country
12.5.2 Market Size (US$ Mn) Forecast, by Country, 2017–2025
12.5.2.1 Japan
12.5.2.2 China
12.5.2.3 India
12.5.2.4 Australia
12.5.2.5 Rest of APAC
12.6 Market Attractiveness Analysis
12.6.1 by Product
12.6.2 by Test Type
12.6.3 by End-user

Section 13 Latin America Hemostasis Diagnostics Market Analysis
13.1 Regional Outlook
13.2 Market Overview
13.3 Market Analysis, by Product
13.3.1 Market Value Share Analysis, by Product
13.3.2 Market Size (US$ Mn) Forecast, by Product
13.3.2.1 Laboratory Systems
13.3.2.1.1 Automated Systems
13.3.2.1.2 Semi-automated Systems
13.3.2.1.3 Manual Systems
13.3.2.2 Consumables
13.3.2.3 Point-of-Care Testing Systems
13.4 Market Analysis, by Test Type
13.4.1 Market Value Share Analysis, by Test Type
13.4.2 Market Size (US$ Mn) Forecast, by Test Type
13.4.2.1 Prothrombin Test Time (PT)
13.4.2.2 Activated partial thromboplastin time (APTT)
13.4.2.3 Fibrinogen degradation products (FDP)
13.4.2.4 Activated Clotting Time
13.4.2.5 Platelet Aggregation Test
13.4.2.6 D Dimer
13.4.2.7 Others
13.4 Market Analysis, by End-user
13.4.1 Market Value Share Analysis, by End-user
13.4.2 Market Size (US$ Mn) Forecast, by End-user
13.4.2.1 Hospital/Clinics
13.4.2.2 Independent Diagnostic Laboratories
13.4.2.3 Home Care Settings
13.4.2.4 Others
13.5 Market Analysis, by Country
13.5.1 Market Value Share Analysis, by Country
13.5.2 Market Size (US$ Mn) Forecast, by Country, 2017–2025
13.5.2.1 Brazil
13.5.2.2 Mexico
13.5.2.3 Rest of LATAM
13.6 Market Attractiveness Analysis
13.6.1 by Product
13.6.2 by Test Type
13.6.3 by End-user

Section 14 Middle East & Africa Hemostasis Diagnostics Market Analysis
14.1 Regional Outlook
14.2 Market Overview
14.3 Market Analysis, by Product
14.3.1 Market Value Share Analysis, by Product
14.3.2 Market Size (US$ Mn) Forecast, by Product
14.3.2.1 Laboratory Systems
14.3.2.1.1 Automated Systems
14.3.2.1.2 Semi-automated Systems
14.3.2.1.3 Manual Systems
14.3.2.2 Consumables
14.3.2.3 Point-of-Care Testing Systems
14.4 Market Analysis, by Test Type
14.4.1 Market Value Share Analysis, by Test Type
14.4.2 Market Size (US$ Mn) Forecast, by Test Type
14.4.2.1 Prothrombin Test Time (PT)
14.4.2.2 Activated partial thromboplastin time (APTT)
14.4.2.3 Fibrinogen degradation products (FDP)
14.4.2.4 Activated Clotting Time
14.4.2.5 Platelet Aggregation Test
14.4.2.6 D Dimer
14.4.2.7 Others
14.4 Market Analysis, by End-user
14.4.1 Market Value Share Analysis, by End-user
14.4.2 Market Size (US$ Mn) Forecast, by End-user
14.4.2.1 Hospital/Clinics
14.4.2.2 Independent Diagnostic Laboratories
14.4.2.3 Home Care Settings
14.4.2.4 Others
14.5 Market Analysis, by Country
14.5.1 Market Value Share Analysis, by Country
14.5.2 Market Size (US$ Mn) Forecast, by Country, 2017–2025
14.5.2.1 South Africa
14.5.2.2 GCC Countries
14.5.2.3 Rest of MEA
14.6 Market Attractiveness Analysis
14.6.1 by Product
14.6.2 by Test Type
14.6.3 by End-user

Section 15 Company Profiles
15.1 Hemostasis Diagnostics Market Share Analysis, by Company (2016)
15.2 Company Profiles
15.2.1 Abbott Laboratories
15.2.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2 Financial Overview
15.2.1.3 Product Portfolio
15.2.1.4 SWOT Analysis
15.2.1.5 Strategic Overview
15.2.2 Alere, Inc.
15.2.2.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2 Financial Overview
15.2.2.3 Product Portfolio
15.2.2.4 SWOT Analysis
15.2.2.5 Strategic Overview
15.2.3 Thermo Fisher Scientific, Inc.
15.2.3.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2 Financial Overview
15.2.3.3 Product Portfolio
15.2.3.4 SWOT Analysis
15.2.3.5 Strategic Overview
15.2.4 F. Hoffmann-La Roche Ltd.
15.2.4.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2 Financial Overview
15.2.4.3 Product Portfolio
15.2.4.4 SWOT Analysis
15.2.4.5 Strategic Overview
15.2.5 Nihon Kohden Corporation
15.2.5.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2 Financial Overview
15.2.5.3 Product Portfolio
15.2.5.4 SWOT Analysis
15.2.5.5 Strategic Overview
15.2.6 Sysmex Corporation
15.2.6.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2 Financial Overview
15.2.6.3 Product Portfolio
15.2.6.4 SWOT Analysis
15.2.6.5 Strategic Overview
15.2.7 Siemens Healthineers
15.2.7.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2 Financial Overview
15.2.7.3 Product Portfolio
15.2.7.4 SWOT Analysis
15.2.7.5 Strategic Overview
15.2.8 Instrumentation Laboratory
15.2.8.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2 Financial Overview
15.2.8.3 Product Portfolio
15.2.8.4 SWOT Analysis
15.2.8.5 Strategic Overview
15.2.9 Danaher Corporation (Beckman Coulter)
15.2.9.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2 Financial Overview
15.2.9.3 Product Portfolio
15.2.9.4 SWOT Analysis
15.2.9.5 Strategic Overview
15.2.10 Grifols, S.A. Preface
15.2.10.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2 Financial Overview
15.2.10.3 Product Portfolio
15.2.10.4 SWOT Analysis
15.2.10.5 Strategic Overview

List of Tables

Table 01: Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 02: Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2015–2025
Table 03: Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 04: Global Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017–2025
Table 05: North America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 06: North America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2017–2025
Table 07: North America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2025
Table 08: North America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2025
Table 09: Europe Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 10: Europe Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2017–2025
Table 11: Europe Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2025
Table 12: Europe Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
Table 13: Asia Pacific Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 14: Asia Pacific Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2017–2025
Table 15: Asia Pacific Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2025
Table 16: Asia Pacific Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
Table 17: Latin America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 18: Latin America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2015–2025
Table 19: Latin America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2025
Table 20: Latin America Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 21: Middle East & Africa Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 22: Middle East & Africa Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2015–2025
Table 23: Middle East & Africa Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2025
Table 24: Middle East & Africa Hemostasis Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025